Thierry Bernard, QIAGEN CEO, joins Yahoo Finance to discuss the future of Covid-19 testing, interest and supply of at-home covid testing, and the diagnostic industry amid the pandemic.
The "tl;dr" (too long, didn't read) scoop on Johnson & Johnson's (NYSE: JNJ) third-quarter results is that they were good overall. J&J's shares opened around 1% higher and picked up more momentum later in the day. Here are three things you might have missed in Johnson & Johnson's Q3 results.
The healthcare giant recorded healthy growth in all three of its business segments and raised its guidance.